Effects of the COVID-19 pandemic on self-reported 12-month pneumococcal vaccination series completion rates in Canada

Routine childhood vaccination improves health and prevents morbidity and mortality from vaccine-preventable diseases. There are indications that the COVID-19 pandemic has negatively impacted immunization rates globally, but systematic studies on this are still lacking in Canada. This study aims to a...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Katherine M. Atkinson (Autor), Blaise Ntacyabukura (Autor), Steven Hawken (Autor), Lucie Laflamme (Autor), Kumanan Wilson (Autor)
Format: Książka
Wydane: Taylor & Francis Group, 2022-12-01T00:00:00Z.
Hasła przedmiotowe:
Dostęp online:Connect to this object online.
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9a31d4b1dc4b4cf5b5775b75eb0cebeb
042 |a dc 
100 1 0 |a Katherine M. Atkinson  |e author 
700 1 0 |a Blaise Ntacyabukura  |e author 
700 1 0 |a Steven Hawken  |e author 
700 1 0 |a Lucie Laflamme  |e author 
700 1 0 |a Kumanan Wilson  |e author 
245 0 0 |a Effects of the COVID-19 pandemic on self-reported 12-month pneumococcal vaccination series completion rates in Canada 
260 |b Taylor & Francis Group,   |c 2022-12-01T00:00:00Z. 
500 |a 2164-5515 
500 |a 2164-554X 
500 |a 10.1080/21645515.2022.2158005 
520 |a Routine childhood vaccination improves health and prevents morbidity and mortality from vaccine-preventable diseases. There are indications that the COVID-19 pandemic has negatively impacted immunization rates globally, but systematic studies on this are still lacking in Canada. This study aims to add knowledge on the pandemic's effect on children's immunization rates with pneumococcal vaccine using self-reported immunization data from CANImmunize. An interrupted time series analysis was conducted on aggregated monthly enrollment of children on the platform (2016-2021) and their pneumococcal immunization series completion rates (2016-2020). Predicted trends before and after the onset of the COVID19-related restriction (March 1, 2020) were compared by means of an Autoregressive Integrated Moving Average (ARIMA). The highest monthly enrollment was 3,474 new infant records observed in January 2020, and the lowest was 100 records in December 2021. The highest Self-reported pneumococcal immunization series completion rate was 78.89%, observed in February 2017, and the lowest was 6.94% in December 2021. Enrollment decreased by 1177.52 records (95% CI: −1865.47, −489.57), with a continued decrease of 80.84 records each month. Completion rates had an immediate increase of 14.57% (95% CI 4.64, 24.51), followed by a decrease of 3.54% each month. The onset of the COVID-19 related restrictions impacted the enrollment of children in the CANImmunize digital immunization platform and an overall decrease in self-reported pneumococcal immunization series completion rates. Our findings support efforts to increase catch-up immunization campaigns so that children who could not get scheduled immunization during the pandemic are not missed. 
546 |a EN 
690 |a childhood vaccines 
690 |a pneumococcal vaccines 
690 |a digital tools 
690 |a interrupted time series 
690 |a covid-19 
690 |a canada 
690 |a Immunologic diseases. Allergy 
690 |a RC581-607 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Human Vaccines & Immunotherapeutics, Vol 18, Iss 7 (2022) 
787 0 |n http://dx.doi.org/10.1080/21645515.2022.2158005 
787 0 |n https://doaj.org/toc/2164-5515 
787 0 |n https://doaj.org/toc/2164-554X 
856 4 1 |u https://doaj.org/article/9a31d4b1dc4b4cf5b5775b75eb0cebeb  |z Connect to this object online.